MannKind Corporation (MNKD)

NASDAQ: MNKD · IEX Real-Time Price · USD
4.08 0.16 (4.08%)
Jan 18, 2022 3:06 PM EST - Market open
Market Cap1.03B
Revenue (ttm)81.37M
Net Income (ttm)-79.28M
Shares Out251.26M
EPS (ttm)-0.32
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,958,530
Open3.98
Previous Close3.92
Day's Range3.88 - 4.18
52-Week Range3.12 - 6.25
Beta1.75
AnalystsBuy
Price Target6.25 (+53.2%)
Earnings DateNov 9, 2021

About MNKD

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. The company offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity used for the treatment of hypothyroidism. The company has a license and collaboration agreement with United Therapeutics Corporation for the development and commercialization of a dry powder formulation of Treprostinil (Tyva...

IndustryBiotechnology
IPO DateJul 28, 2004
CEOMichael Castagna
Employees240
Stock ExchangeNASDAQ
Ticker SymbolMNKD
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 6 analysts, the average rating for MannKind stock is "Buy." The 12-month stock price forecast is 6.25, which is an increase of 53.19% from the latest price.

Price Target
$6.25
(53.19% upside)
Analyst Consensus: Buy

News

MannKind Corporation to Participate in H.C. Wainwright Bioconnect Conference

DANBURY, Conn., Jan. 05, 2022 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with endocr...

1 week ago - GlobeNewsWire

MannKind Extends Collaboration With Thirona Bio on Fibrotic Lung Diseases

DANBURY, Conn., Jan. 05, 2022 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with endocr...

1 week ago - GlobeNewsWire

MannKind Corporation to Participate in the Lytham Partners Winter 2021 Investor Conference

WESTLAKE VILLAGE, Calif., Dec. 06, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients w...

1 month ago - GlobeNewsWire

MannKind (MNKD) Reports Q3 Loss, Tops Revenue Estimates

MannKind (MNKD) delivered earnings and revenue surprises of 20.00% and 8.16%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

Recap: MannKind Q3 Earnings

MannKind (NASDAQ:MNKD) reported its Q3 earnings results on Tuesday, November 9, 2021 at 04:00 PM. Here's what investors need to know about the announcement.

2 months ago - Benzinga

Mannkind Corporation Closes Sale-Leaseback Transaction Generating $102.25 Million in Non-Dilutive Gross Proceeds

WESTLAKE VILLAGE, Calif. and DANBURY, Conn., Nov. 09, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic prod...

2 months ago - GlobeNewsWire

MannKind Presents Data at 21st Annual Diabetes Technology Meeting

WESTLAKE VILLAGE, Calif., Nov. 05, 2021 (GLOBE NEWSWIRE) --  MannKind Corporation (Nasdaq: MNKD), which focuses on the development of innovative medicines for patients with endocrine and orphan lung dis...

2 months ago - GlobeNewsWire

MannKind Corporation to Hold 2021 Third Quarter Financial Results Conference Call on November 9, 2021

WESTLAKE VILLAGE, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) will release its 2021 third quarter financial results and its management will host a conference call to dis...

2 months ago - GlobeNewsWire

Will MannKind (MNKD) Report Negative Q3 Earnings? What You Should Know

MannKind (MNKD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago - Zacks Investment Research

Why Shares of MannKind Corporation Are Falling This Morning

Investors are hyperventilating after a delay for its inhaled medicine.

3 months ago - The Motley Fool

MNKD Stock: The Disappointing FDA News That Has MannKind Shares Diving Today

MannKind (MNKD) stock is taking a beating on Monday after releasing an update to investors concerning news from the FDA for Tyvaso DPI. The post MNKD Stock: The Disappointing FDA News That Has MannKind ...

3 months ago - InvestorPlace

MannKind's stock falls 18% after FDA says it will not approve application for hypertension drug

Shares of MannKind Corp. MNKD, -17.68% tumbled 18.3% in trading on Monday after the company said the Food and Drug Administration would not approve a pulmonary arterial hypertension treatment it is deve...

3 months ago - Market Watch

Why MannKind Shares Are Falling Today

MannKind Corp (NASDAQ: MNKD) is trading significantly lower Monday morning after the company announced the FDA issued a complete response to United Therapeutics regarding the New Drug Application for Ty...

3 months ago - Benzinga

FDA Declines MannKind - United Therapeutics' Formulated Treprostinil For Lung Disease

The FDA has issued a complete response to United Therapeutics Corporation (NASDAQ: UTHR) regarding the marketing application for Tyvaso DPI for pulmonary arterial hypertension (PAH) and pulmonary hypert...

Other symbols:UTHR
3 months ago - Benzinga

Progress Update on Tyvaso DPI™ New Drug Application

WESTLAKE VILLAGE, Calif. and DANBURY, Conn., Oct. 18, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic prod...

3 months ago - GlobeNewsWire

Do Options Traders Know Something About MannKind (MNKD) Stock We Don't?

Investors need to pay close attention to MannKind (MNKD) stock based on the movements in the options market lately.

3 months ago - Zacks Investment Research

MannKind Announces First Patient Enrolled In Inhale-1 Study Of Afrezza® In Pediatric Population

WESTLAKE VILLAGE, Calif., Oct. 4, 2021 /PRNewswire/ -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with e...

3 months ago - PRNewsWire

5 Penny Stocks To Watch This Week With Potential Biotech Catalysts

Will upcoming events mean big things for these penny stocks? The post 5 Penny Stocks To Watch This Week With Potential Biotech Catalysts appeared first on Penny Stocks to Buy, Picks, News and Informatio...

Other symbols:ABUSADVMKLDOTRVN
3 months ago - PennyStocks

Mannkind Corporation Announces Sale-Leaseback Transaction Generating $102.25 Million in Non-Dilutive Gross Proceeds

WESTLAKE VILLAGE, Calif. and DANBURY, Conn., Sept. 29, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic pro...

3 months ago - GlobeNewsWire

MannKind Corporation to Participate at Lytham Partners Fall 2021 Investor Conference

WESTLAKE VILLAGE, Calif., Sept. 28, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients ...

3 months ago - GlobeNewsWire

Mannkind Corporation Participating at Upcoming Conferences

WESTLAKE VILLAGE, Calif., Sept. 15, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients ...

4 months ago - GlobeNewsWire

MannKind Corporation to Participate in H.C. Wainwright 23rd Annual Global Investment Conference

WESTLAKE VILLAGE, Calif., Sept. 07, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients ...

4 months ago - GlobeNewsWire

The 6 Best Penny Stocks to Buy for September

Investing in penny stocks can be an intriguing numbers game. With many stocks to choose from, a handful are bound to be winners.

Other symbols:BIOLMMATRMOINUVDATS
4 months ago - InvestorPlace

8 Best Penny Stocks To Buy Right Now According To Insiders

Insiders are buying these penny stocks right now. Should you?

Other symbols:QUMUSRGA
5 months ago - PennyStocks

Best Penny Stocks To Buy Right Now? 5 To Watch Before September

Looking for penny stocks to buy now? The post Best Penny Stocks To Buy Right Now?

Other symbols:INUVMICTRLX
5 months ago - PennyStocks